Scarica l'app Stockscreener
1.79
1.10%
-0.02
Precedente Chiudi:
$1.81
Aprire:
$1.8
Volume 24 ore:
32,699
Relative Volume:
0.32
Capitalizzazione di mercato:
$75.84M
Reddito:
$6.21M
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-1.7048
EPS:
-1.05
Flusso di cassa netto:
$-16.76M
1 W Prestazione:
+0.56%
1M Prestazione:
-4.79%
6M Prestazione:
-19.37%
1 anno Prestazione:
-33.95%
Intervallo 1D:
$1.79
$1.8522
Intervallo di 1 settimana:
$1.74
$1.95
Portata 52W:
$1.59
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Nome
InspireMD Inc.
Settore
Industria
Telefono
972 3 6917691
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Confronta NSPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.79 | 76.69M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2016-01-07 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Iniziato | Oppenheimer | Outperform |
InspireMD Inc. Borsa (NSPR) Ultime notizie
InspireMD (NYSE:NSPR) Trading Down 6.2% – Should You Sell? - Defense World
InspireMD (NSPR) price target decreased by 11.11% to 4.08 - MSN
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS) - Defense World
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Sahm
Will InspireMD Inc. stock gain from lower inflationWeekly Trade Analysis & Low Risk Entry Point Guides - Улправда
Working capital per share of InspireMD Inc. – DUS:II2 - TradingView — Track All Markets
Will InspireMD Inc. (II2) stock outperform value peers2025 Technical Patterns & Real-Time Volume Analysis - Улправда
Can InspireMD Inc. stock hit record highs again2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
Aug Update: Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Catalysts & Safe Capital Preservation Plans - Улправда
Why InspireMD Inc. stock is considered a top pickJuly 2025 Highlights & Weekly High Return Forecasts - Улправда
Will InspireMD Inc. (II2) stock profit from fiscal stimulusBreakout Watch & Verified Momentum Watchlists - Улправда
InspireMD’s new study on neuroprotection system: A potential game-changer? - MSN
Why InspireMD Inc. stock could be next big winnerTreasury Yields & Risk Managed Investment Strategies - DonanımHaber
Will InspireMD Inc. stock continue dividend increases2025 EndofYear Setup & Real-Time Volume Analysis Alerts - DonanımHaber
Is InspireMD Inc a good long term investmentREITs Market Trends & Capital Efficiency Improvement - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
Aug Big Picture: Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Momentum & Entry Point Confirmation Signals - Улправда
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer? - TipRanks
Aug Selloffs: How InspireMD Inc stock compares to growth peers2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Head-To-Head Review: Biotricity (NASDAQ:BTCY) versus InspireMD (NYSE:NSPR) - Defense World
Peter A. Soukas Joins InspireMD as Chief Medical Officer - Medical Product Outsourcing
Investment Report: Will InspireMD Inc stock gain from lower inflationWeekly Stock Analysis & Reliable Price Breakout Signals - moha.gov.vn
Total debt per share of InspireMD Inc. – MUN:II2 - TradingView
InspireMD Director Paul Stuka Acquires 10,130 Shares - TradingView
Dir Stuka Buys 10,130 ($18.7K) Of InspireMD Inc [NSPR] - TradingView — Track All Markets
Can InspireMD Inc. (II2) stock survive global slowdownM&A Rumor & High Conviction Trade Alerts - Newser
Is InspireMD Inc. (II2) stock supported by strong fundamentalsWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
InspireMD (NSPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Financial Contrast: InspireMD (NYSE:NSPR) vs. Biostage (OTCMKTS:BSTG) - Defense World
How InspireMD Inc. stock performs in rate cut cyclesTreasury Yields & Verified Swing Trading Watchlists - BỘ NỘI VỤ
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
InspireMD (NYSE:NSPR) Shares Up 2%Should You Buy? - MarketBeat
InspireMD announces publication of CREST-2 data in NEJM - MSN
Lake Street Reaffirms Their Buy Rating on InspireMD (NSPR) - The Globe and Mail
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
InspireMD Celebrates Positive Outcomes from CREST-2 Study Supporting Carotid Stenting for Asymptomatic Patients - Quiver Quantitative
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - The Manila Times
Landmark CREST-2 Study Published in the New England Journal - GlobeNewswire
InspireMD announces inducement grants - Medical Buyer
InspireMD Reports Record Revenue Amid U.S. Launch - MSN
What analysts say about InspireMD Inc stockMarket Correction Analysis & Low Entry Cost Trading - earlytimes.in
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD (Nasdaq: NSPR) grants 122,054 inducement shares to eight new hires - Stock Titan
What catalysts could drive InspireMD Inc. stock higherEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Is InspireMD Inc. (II2) stock suitable for passive index fundsOil Prices & Capital Protection Trade Alerts - newser.com
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Why analysts remain bullish on InspireMD Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Applying sector rotation models to InspireMD Inc.Quarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
InspireMD Inc. Azioni (NSPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):